Question · asked by 1 review
Intravesically administered BCG combined with IFN‐α vs intravesically administered BCG alone: Disease‐specific quality of life ‐ not reported
- Population
- patients with non‐muscle invasive bladder cancer
- Intervention
- Intravesically administered BCG combined with IFN‐α
- Comparison
- intravesically administered BCG alone
- Outcome
- Disease‐specific quality of life ‐ not reported
The review found no eligible studies for this question.
What each review found
Include earlier review versions| Finding | Effect | Studies | GRADE certainty |
|---|---|---|---|
Intravesically administered BCG combined with IFN‐α vs intravesically administered BCG alone Disease‐specific quality of life ‐ not measured · patients with non‐muscle invasive bladder cancer The review found no eligible studies for this question. Intravesical Bacillus Calmette‐Guérin with interferon‐alpha versus intravesical Bacillus Calmette‐Guérin for… (2017) · Cochrane Headline outcomes only | no estimate extracted | Not reported | No studies found |
Findings are shown side by side, never pooled across reviews.
The reviews
| Review | Searched up to | Included studies | AMSTAR 2 |
|---|---|---|---|
| Intravesical Bacillus Calmette‐Guérin with interferon‐alpha versus intravesical Bacillus Calmette‐Guérin for treating non‐muscle‐invasive… 2017 · Cochrane Headline outcomes only | Not reported | Not extracted | Not assessed |
How reviews are matched to this question
Reviews word the same question differently. Four decision models (TypeSafe's Jev, Liquid AI's d1-ultra, SubQ Snap and Baseten's Elephant) judged each wording of the population, intervention, comparator and outcome against the others; two wordings count as the same when at least three of them agree and none clearly disagrees, and findings count as this question only when all four elements match. Timing, setting and subgroup never split a question: they are shown on each finding.